Archive for the ‘Atypical antipsychotic’ tag

Saphris for Bipolar disorder and schizophrenia launch ad

without comments

Page 1 of 8

Merck and Schering just launched Saphris, a new atypical antipsychotic for Bipolar I disorder and schizophrenia.

You can see the 8-page launch ad to healthcare professionals on AdPharm.

This ad and thousands more can be seen on the AdPharm gallery, the largest keyword searchable online pharmaceutical advertising gallery.

New Geodon HCP campaign

without comments

Brand name: Geodon
Generic name/category: Ziprasidone, Atypical antipsychotic
Company: Pfizer
Country/Market: USA, North America
Indication(s)/use: acute agitation in schizophrenic patients and acute treatment of mania and mixed states associated with bipolar disorder
Target: Healthcare Professionals (HCP)
Tagline: See me for who I can be
Medium: Print ad
Size/duration: single-page
Publication/Aired: October and November 2009

To see all of this brand’s ads on AdPharm, click here

AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.